000 | 01900 a2200649 4500 | ||
---|---|---|---|
005 | 20250513203428.0 | ||
264 | 0 | _c20000317 | |
008 | 200003s 0 0 eng d | ||
022 | _a0163-2116 | ||
024 | 7 |
_a10.1023/a:1005473729976 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aShiota, G | |
245 | 0 | 0 |
_aCirculating p53 antibody in patients with colorectal cancer: relation to clinicopathologic features and survival. _h[electronic resource] |
260 |
_bDigestive diseases and sciences _cJan 2000 |
||
300 |
_a122-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntibodies, Neoplasm _xblood |
650 | 0 | 4 |
_aBiomarkers, Tumor _xblood |
650 | 0 | 4 |
_aCA-19-9 Antigen _xblood |
650 | 0 | 4 |
_aCarcinoembryonic Antigen _xblood |
650 | 0 | 4 |
_aColonic Polyps _xdiagnosis |
650 | 0 | 4 |
_aColorectal Neoplasms _xdiagnosis |
650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aRegression Analysis |
650 | 0 | 4 | _aSurvival Rate |
650 | 0 | 4 |
_aTumor Suppressor Protein p53 _ximmunology |
700 | 1 | _aIshida, M | |
700 | 1 | _aNoguchi, N | |
700 | 1 | _aOyama, K | |
700 | 1 | _aTakano, Y | |
700 | 1 | _aOkubo, M | |
700 | 1 | _aKatayama, S | |
700 | 1 | _aTomie, Y | |
700 | 1 | _aHarada, K | |
700 | 1 | _aHori, K | |
700 | 1 | _aAshida, K | |
700 | 1 | _aKishimoto, Y | |
700 | 1 | _aHosoda, A | |
700 | 1 | _aSuou, T | |
700 | 1 | _aKanbe, T | |
700 | 1 | _aTanaka, K | |
700 | 1 | _aNosaka, K | |
700 | 1 | _aTanida, O | |
700 | 1 | _aKojo, H | |
700 | 1 | _aMiura, K | |
700 | 1 | _aIto, H | |
700 | 1 | _aKaibara, N | |
700 | 1 | _aKawasaki, H | |
773 | 0 |
_tDigestive diseases and sciences _gvol. 45 _gno. 1 _gp. 122-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1023/a:1005473729976 _zAvailable from publisher's website |
999 |
_c10649743 _d10649743 |